Viral Gene Therapy
| dc.contributor.editor | Xu, Ke | |
| dc.date.accessioned | 2021-04-20T15:07:11Z | |
| dc.date.available | 2021-04-20T15:07:11Z | |
| dc.date.issued | 2011 | |
| dc.identifier | ONIX_20210420_9789533075396_377 | |
| dc.identifier.uri | https://directory.doabooks.org/handle/20.500.12854/65021 | |
| dc.description.abstract | The development of technologies that allow targeting of specific cells has progressed substantially in recent years for several types of vectors, particularly viral vectors, which have been used in 70% of gene therapy clinical trials. Particular viruses have been selected as gene delivery vehicles because of their capacities to carry foreign genes and their ability to efficiently deliver these genes associated with efficient gene expression. This book is designed to present the most recent advances in viral gene therapy | |
| dc.language | English | |
| dc.subject.classification | thema EDItEUR::M Medicine and Nursing::MF Pre-clinical medicine: basic sciences::MFN Medical genetics | en_US |
| dc.subject.other | Medical genetics | |
| dc.title | Viral Gene Therapy | |
| dc.type | book | |
| oapen.identifier.doi | 10.5772/1011 | |
| oapen.relation.isPublishedBy | 78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6 | |
| oapen.relation.isbn | 9789533075396 | |
| oapen.relation.isbn | 9789535164388 | |
| oapen.imprint | IntechOpen | |
| oapen.pages | 464 |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described
as
https://creativecommons.org/licenses/by-nc-sa/3.0/